My Dear People,
In the Year 2016, a vision given by God to Ms. Chamidi Keshani (My Sister) to open an educational institute for girls or ladies, which can give them a bright future in this competitive world for Free. 106 more words
By Ben Hirschler
LONDON (Reuters) – AstraZeneca’s high hopes for cancer immunotherapy were dented on Thursday as the recruitment of new patients with head and neck cancer into two clinical studies was put on hold, following instances of bleeding. 358 more words
Alexion Pharmaceuticals has announced the initiation of two Phase 3 trials of ALXN1210, a highly innovative, longer-acting anti-C5 antibody that inhibits terminal complement.
The first trial is a Phase 3 open-label, multinational, active-controlled study of ALXN1210 compared to eculizumab (Soliris) in complement inhibitor treatment-naïve patients with paroxysmal nocturnal hemoglobinuria (PNH), said the company in its press release. 237 more words